A Study to Assess the Efficacy and Safety of YM060 in Female Patients With Diarrhea-predominant Irritable Bowel Syndrome (IBS)
Clinical trial NCT01870895 · COMPLETED
Trial details
- NCT number
- NCT01870895
- Sponsor
- Astellas Pharma Inc
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-02-01
- Primary completion
- 2014-02-01
- Enrollment
- 577
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.